Frontline Chemo-Free Induction Effective in Younger MCL

Response rate of 98% with ibrutinib-rituximab in mantle cell lymphoma patients 65 and under

Related Keywords

Italy ,Houston ,Texas ,United States ,Candiolo ,Piemonte ,Massachusetts ,Mattia Novo ,Michaell Wang ,Umberto Vitolo ,Mike Bassett ,Candiolo Cancer Institute In Turin ,University Of Texas Md Anderson Cancer Center ,Md Anderson Cancer Center ,Mantle Cell Lymphoma International Prognostic Index ,Eastern Cooperative Oncology Group ,Cancer Center ,Candiolo Cancer Institute ,